oxytetracycline

oxytetracycline is a lipid of Polyketides (PK) class. Oxytetracycline is associated with abnormalities such as Infection, X-linked centronuclear myopathy, Bacterial Infections, Heart failure and Onchocerciasis. The involved functions are known as Anabolism, physiological aspects, Transcription, Genetic, Fermentation and Transcriptional Activation. Oxytetracycline often locates in Chromosomes, Flank (surface region), Entire bony skeleton, Bone Marrow and Body tissue. The associated genes with oxytetracycline are Polypeptides, Homologous Gene, Gene Clusters, Locus and CYCS gene. The related lipids are LH 1 and Lipid Peroxides. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of oxytetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with oxytetracycline?

oxytetracycline is suspected in Infection, Helminthiasis, Nodule, Bacterial Infections, Yeast infection, pathologic fistula and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with oxytetracycline

MeSH term MeSH ID Detail
Digital Dermatitis D058066 3 associated lipids
Anaplasmosis D000712 3 associated lipids
Phagocyte Bactericidal Dysfunction D010585 3 associated lipids
Ectromelia D004480 3 associated lipids
Esophageal Diseases D004935 3 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Bone Cysts D001845 3 associated lipids
Hemorrhagic Disorders D006474 3 associated lipids
Jejunal Diseases D007579 3 associated lipids
Per page 10 20 50 100 | Total 137

PubChem Associated disorders and diseases

What pathways are associated with oxytetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with oxytetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with oxytetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with oxytetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with oxytetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with oxytetracycline?

Disease model

Disease model are used in the study 'A molecular ecological approach to the detection and designation of the etiological agents of a model polymicrobial disease.' (Antiabong JF et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with oxytetracycline

Download all related citations
Per page 10 20 50 100 | Total 5138
Authors Title Published Journal PubMed Link
Magonigle RA and Newby TJ Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections. 1984 Am. J. Vet. Res. pmid:6731981
Roby TO et al. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline. 1978 Am. J. Vet. Res. pmid:677530
Teare JA et al. Pharmacokinetics of a long-acting oxytetracycline preparation in ring-necked pheasants, great horned owls, and Amazon parrots. 1985 Am. J. Vet. Res. pmid:4083606
Magonigle RA et al. Efficacy of a new oxytetracycline formulation against clinical anaplasmosis. 1978 Am. J. Vet. Res. pmid:697150
George LW et al. Effectiveness of two benzathine cloxacillin formulations for treatment of naturally occurring infectious bovine keratoconjunctivitis. 1989 Am. J. Vet. Res. pmid:2774340
DOZSA L and OLSON NO THE EFFECT OF VARIOUS ANTIBIOTICS ON THE UTERINE MUCOSA OF VIBRIO FETUS-INFECTED COWS. 1964 Am. J. Vet. Res. pmid:14103211
Kniffen TS et al. Bioavailability, pharmacokinetics, and plasma concentration of tetracycline hydrochloride fed to swine. 1989 Am. J. Vet. Res. pmid:2712418
Varma KJ and Paul BS Pharmacokinetics and plasma protein binding (in vitro) of oxytetracycline in buffalo (Bubalus bubalis). 1983 Am. J. Vet. Res. pmid:6838044
Dyer DC Pharmacokinetics of oxytetracycline in the turkey: evaluation of biliary and urinary excretion. 1989 Am. J. Vet. Res. pmid:2712419
Rohde C et al. Effects of phenylbutazone on bone activity and formation in horses. 2000 Am. J. Vet. Res. pmid:10803649
Wooley RE et al. Attempted reversal of oxytetracycline resistance of Proteus mirabilis by EDTA-tromethamine lavage in experimentally induced canine and feline cystitis. 1975 Am. J. Vet. Res. pmid:811139
Bretzlaff KN et al. Distribution of oxytetracycline in the healthy and diseased postpartum genital tract of cows. 1983 Am. J. Vet. Res. pmid:6869979
VanEnkevort BA et al. Alterations in bone remodeling in the femur after medullary reaming and cemented hip arthroplasty in dogs. 1999 Am. J. Vet. Res. pmid:10451197
Davis RW et al. The effects of an oxytetracycline preparation on the thyroid gland: a preliminary report. 1966 Am. J. Vet. Res. pmid:5913021
Miller RA and Reimschuessel R Epidemiologic cutoff values for antimicrobial agents against Aeromonas salmonicida isolates determined by frequency distributions of minimal inhibitory concentration and diameter of zone of inhibition data. 2006 Am. J. Vet. Res. pmid:17078743
Owen RA et al. Effects of transportation, surgery, and antibiotic therapy in ponies infected with Salmonella. 1983 Am. J. Vet. Res. pmid:6337537
Toofanian F and Targowski S Experimental production of rabbit mucoid enteritis. 1983 Am. J. Vet. Res. pmid:6346966
Wooley RE et al. In vitro action of combinations of antimicrobial agents and EDTA-tromethamine on Pseudomonas aeruginosa. 1983 Am. J. Vet. Res. pmid:6414345
Simpson CF Morphologic alterations of Anaplasma marginale in calves after treatment with oxytetracycline. 1975 Am. J. Vet. Res. pmid:1190584
Brown MP and MacCallum FJ A system of grading ossification in limbs of foals to assist in radiologic interpretation. 1975 Am. J. Vet. Res. pmid:1137212
BARNES LE Oxytetracycline in bovine mastitis. I. Treatment of mastitis. 1955 Am. J. Vet. Res. pmid:13238740
Hewson J et al. Impact of isoflupredone acetate treatment on clinical signs and weight gain in weanling heifers with experimentally induced Mannheimia haemolytica bronchopneumonia. 2011 Am. J. Vet. Res. pmid:22126689
Pindak FF et al. Incidence and distribution of spirochetes in the digestive tract of dogs. 1965 Am. J. Vet. Res. pmid:5882556
Guerra MA and Nicoletti P Comparison of the susceptibility of Brucella abortus isolates obtained before and after cows were treated with oxytetracycline and streptomycin. 1986 Am. J. Vet. Res. pmid:3099613
Bretzlaff KN et al. Distribution of oxytetracycline in the genital tract of cows. 1982 Am. J. Vet. Res. pmid:7091807
Lincoln SD et al. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period. 1982 Am. J. Vet. Res. pmid:7103219
Arnoczky SP et al. In vitro effects of oxytetracycline on matrix metalloproteinase-1 mRNA expression and on collagen gel contraction by cultured myofibroblasts obtained from the accessory ligament of foals. 2004 Am. J. Vet. Res. pmid:15077693
Palmer JE et al. Effect of treatment with oxytetracycline during the acute stages of experimentally induced equine ehrlichial colitis in ponies. 1992 Am. J. Vet. Res. pmid:1476312
Oukessou M et al. Pharmacokinetics and local tolerance of a long-acting oxytetracycline formulation in camels. 1992 Am. J. Vet. Res. pmid:1416372
Magonigle RA and Newby TJ Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable. 1982 Am. J. Vet. Res. pmid:7165161
Kuttler KL Efficacy of oxytetracycline and a dithiosemicarbazone in the treatment of bovine anaplasmosis. 1971 Am. J. Vet. Res. pmid:5094519
Riner JL et al. Influence of density and location on degradation of sustained-release boluses given to cattle. 1982 Am. J. Vet. Res. pmid:7181203
Hatch RC et al. Effect of antibacterials, anabolic steroid, and diethyldithiocarbamate on induced acute aflatoxicosis in goats. 1982 Am. J. Vet. Res. pmid:6280533
Gross DR et al. Cardiovascular effects of intravenous administration of propylene glycol and of oxytetracycline in propylene glycol in calves. 1979 Am. J. Vet. Res. pmid:475130
Abbitt B et al. Effect of dihydrostreptomycin or oxytetracycline on reproductive capacity of bulls. 1984 Am. J. Vet. Res. pmid:6084431
byford RL et al. Chemoprophylaxis of vector-borne anaplasmosis with sustained-release boluses. 1981 Am. J. Vet. Res. pmid:7340579
McElroy DE et al. Pharmacokinetics of oxytetracycline hydrochloride in rabbits. 1987 Am. J. Vet. Res. pmid:3631718
Larson VL and Stowe CM Plasma and tissue concentrations of oxytetracycline in the horse after intravenous administration. 1981 Am. J. Vet. Res. pmid:7340586
Hidalgo RJ Propagation of Anaplasma marginale in bovine lymph node cell culture. 1975 Am. J. Vet. Res. pmid:1094867
BARNES LE Oxytetracycline in bovine mastitis. II. Milk levels following local and parenteral administration. 1956 Am. J. Vet. Res. pmid:13283224
Fielding CL et al. Evaluation of potential predictor variables for PCR assay diagnosis of Anaplasma phagocytophilum infection in equids in Northern California. 2018 Am. J. Vet. Res. pmid:30085857
Anderson KL et al. Potential for oxytetracycline administration by three routes to cause milk residues in lactating cows, as detected by radioimmunoassay (Charm II) and high-performance liquid chromatography test methods. 1995 Am. J. Vet. Res. pmid:7695153
Moats WA et al. Comparison of a radioimmunoassay (Charm II) test with high-performance liquid chromatography for detection of oxytetracycline residues in milk samples from lactating cattle. 1995 Am. J. Vet. Res. pmid:7653890
Simpson CF Morphologic alteration of Paranaplasma caudata following treatment of calves with oxytetracycline. 1977 Am. J. Vet. Res. pmid:931133
Button C and Mülders MS Effects of oxytetracycline in propylene glycol, oxytetracycline in saline solution, and propylene glycol alone on blood ionized calcium and plasma total calcium in sheep. 1984 Am. J. Vet. Res. pmid:6476580
Tornquist SJ et al. Use of a polymerase chain reaction assay to study response to oxytetracycline treatment in experimental Candidatus Mycoplasma haemolamae infection in alpacas. 2009 Am. J. Vet. Res. pmid:19719425
Smith JA and George LW Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation. 1985 Am. J. Vet. Res. pmid:4014830
Milward FW et al. Effectiveness of various therapeutic regimens for bovine brucellosis. 1984 Am. J. Vet. Res. pmid:6208830
Fecteau KA and Eiler H Evaluation of injections of collagenase and oxytetracycline via the umbilical artery as treatment for retained placenta in cattle. 1996 Am. J. Vet. Res. pmid:8712518
Myers MJ et al. In vitro modulation of bovine blood neutrophils and mononuclear cells by oxytetracycline. 1995 Am. J. Vet. Res. pmid:8533970